Proposition de loi modifiant le Code de droit économique afin d'instaurer une procédure efficace de délivrance de licences obligatoires pour les médicaments.

This Belgian parliamentary bill would amend the Economic Law Code to create a more efficient procedure for granting compulsory licences for medicines. A compulsory licence lets a government authorise another producer to make a patented product without the patent holder's consent, usually in exchange for compensation. The bill aims to make that process faster and more workable. Based on metadata only, not the full legislative text. The change would mainly affect pharmaceutical patent holders, generic and other manufacturers seeking to produce patented medicines, and patients who depend on access to affordable treatments. Health authorities and the Belgian courts or administrations involved in issuing licences would also be affected.